EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieOpen access · CC BY 4.0

Metformin attenuates metabolic insulin sensitivity and insulin‐stimulated carbohydrate oxidation after high‐intensity exercise training in adults at risk for metabolic syndrome

Steven K Malin iD, Emily M Heiston, Daniel J Battillo, Tristan J Ragland, Anna Ballantyne, Sue A Shapses, Ankit M Shah, James T Patrie

Diabetes, Obesity and Metabolism · 2026-04 · 28 (4) · 2941-2952

DOI: 10.1111/dom.70478 ↗

At a glance

Randomisierte kontrollierte Studie in Diabetes, Obesity and Metabolism, 2026-04. Written by Steven K Malin and 7 co-authors. Institution: Department of Kinesiology and Health, Rutgers University, New Brunswick, New Jersey, USA. Major MEDLINE topics: Metformin, Metabolic Syndrome, Insulin Resistance, Hypoglycemic Agents. 43 references. The full text is freely available (open access, CC BY 4.0). Funded by: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aims

Mixed evidence exists on whether metformin adds to or attenuates the insulin‐sensitising effects of exercise. To date, no studies have tested whether metformin differentially impacts exercise training intensity–mediated insulin sensitivity. We tested the hypothesis that metformin would blunt metabolic insulin sensitivity and carbohydrate oxidation in an intensity‐based manner among adults with metabolic syndrome (MetS) risk. Materials and methods In a double‐blind, placebo‐controlled trial, participants were randomised to low‐intensity exercise plus placebo (~55% VO 2 max 5 days/week, LoEx + PL, n = 22) or metformin (2000 mg/day, LoEx + Met, n = 21) and high‐intensity exercise plus placebo (~85% VO 2 max 5 days/week, HiEx + PL, n = 24) or metformin (HiEx + Met, n = 24) for 16 weeks. A 120‐min euglycaemic–hyperinsulinemic clamp (40 mU/m 2 /min, 90 mg/dL) was conducted pre‐ and post‐treatment to assess metabolic insulin sensitivity (M‐value/insulin). Fasting and insulin‐stimulated carbohydrate oxidation was also assessed using indirect calorimetry. Adipokines (leptin, high molecular weight (HWM), and total adiponectin) were measured at 0 and 120 min of the clamp. Aerobic fitness (VO 2 max) and body composition (DXA) were also analysed.

Results

HiEx + PL increased metabolic insulin sensitivity ( p = 0.017) while HiEx + Met, LoEx + PL, or LoEx + Met did not. HiEx + PL also raised insulin‐stimulated carbohydrate oxidation and decreased fat oxidation compared with LoEx + Met (both, p = 0.008). Increased metabolic insulin sensitivity related to reductions in fasting glucose ( r = −0.41, p = 0.025), VO 2 max ( r = 0.55, p = 0.002), fasting leptin ( r = −0.54, p = 0.01), and weight loss ( r = −0.60, p < 0.001) after exercise and placebo, but not exercise and metformin.

Conclusions

Metformin attenuated metabolic insulin sensitivity and insulin‐stimulated carbohydrate oxidation after high‐intensity exercise training in adults at risk for MetS.

Subjects

MeSH terms (MEDLINE)

MetforminMetabolic SyndromeInsulin ResistanceHypoglycemic AgentsCarbohydrate MetabolismExerciseHigh-Intensity Interval TrainingHumansDouble-Blind MethodFemaleMaleOxidation-ReductionMiddle AgedAdultInsulinGlucose Clamp TechniqueBlood Glucose

Author keywords

fat metabolisminsulin sensitivityobesityphysical activitytype 2 diabetes

Substances

MetforminHypoglycemic AgentsInsulinBlood Glucose

Authors and institutions

  • Department of Kinesiology and Health, Rutgers University, New Brunswick, New Jersey, USA.
  • Division of Endocrinology, Metabolism and Nutrition, Department of Medicine, Rutgers University, New Brunswick, New Jersey, USA.
  • New Jersey Institute for Food, Nutrition and Health, Rutgers University, New Brunswick, New Jersey, USA.
  • Institute of Translational Medicine and Science, Rutgers University, New Brunswick, New Jersey, USA.
  • Department of Health, Human Performance, and Recreation, Pittsburg State University, Pittsburg, Kansas, USA.
  • Department of Education, University of Virginia, Charlottesville, Virginia, USA.

ORCID profiles: Steven K Malin

Funding

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Cite

APA

Malin, S. K., Heiston, E. M., Battillo, D. J., Ragland, T. J., Ballantyne, A., Shapses, S. A., Shah, A. M., & Patrie, J. T. (2026). Metformin attenuates metabolic insulin sensitivity and insulin‐stimulated carbohydrate oxidation after high‐intensity exercise training in adults at risk for metabolic syndrome. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70478

Vancouver

Malin SK, Heiston EM, Battillo DJ, Ragland TJ, Ballantyne A, Shapses SA, et al. Metformin attenuates metabolic insulin sensitivity and insulin‐stimulated carbohydrate oxidation after high‐intensity exercise training in adults at risk for metabolic syndrome. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70478

BibTeX
@article{Malin2026,
  author = {Malin, Steven K and Heiston, Emily M and Battillo, Daniel J and Ragland, Tristan J and Ballantyne, Anna and Shapses, Sue A and Shah, Ankit M and Patrie, James T},
  title = {Metformin attenuates metabolic insulin sensitivity and insulin‐stimulated carbohydrate oxidation after high‐intensity exercise training in adults at risk for metabolic syndrome},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70478}
}
Start for free →